Antigen processing in the endoplasmic reticulum is monitored by semi-invariant αβ tcrs specific for a conserved peptide-qa-1b MHC class ib ligand

Journal of Immunology

Volumn 198, Issue 5, 2017, Pages 2017-2027

  Guan, Jian ^a,b   Yang, Soo Jung ^b   Gonzalez, Federico ^b   Yin, Yuxin ^a   Shastri, Nilabh ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ENDOPLASMIC RETICULUM AMINOPEPTIDASE ASSOCIATED WITH ANTIGEN PROCESSING PROTEIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEIN VARIANT; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRAJ21 ALPHA CHAIN PROTEIN; TRAV9D 3 PROTEIN; TRBD1 PROTEIN; TRBJ2 7 BETA CHAIN PROTEIN; TRBV5 PROTEIN; UNCLASSIFIED DRUG; ANTIGEN; CYTOSOL AMINOPEPTIDASE; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; PUROMYCIN-INSENSITIVE LEUCYL-SPECIFIC AMINOPEPTIDASE; Q SURFACE ANTIGENS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BIOLOGICAL MONITORING; CELL SPECIFICITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE REARRANGEMENT; GENETIC CONSERVATION; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; T LYMPHOCYTE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL CULTURE; CONSERVED SEQUENCE; GENETIC VARIATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SINGLE CELL ANALYSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CONSERVED SEQUENCE; ENDOPLASMIC RETICULUM; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; LEUCYL AMINOPEPTIDASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SINGLE-CELL ANALYSIS;

EID: 85014895658     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600764     Document Type: Article

References (58)

1. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20: 463-493.
2. Blum, J. S., P. A. Wearsch, and P. Cresswell. 2013. Pathways of antigen processing. Annu. Rev. Immunol. 31: 443-473.
3. Neefjes, J., M. L. Jongsma, P. Paul, and O. Bakke. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
4. Shastri, N., S. Cardinaud, S. R. Schwab, T. Serwold, and J. Kunisawa. 2005. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207: 31-41.
5. Rock, K. L., D. J. Farfán-Arribas, J. D. Colbert, and A. L. Goldberg. 2014. Reexamining class-I presentation and the DRiP hypothesis. Trends Immunol. 35: 144-152.
6. Van Kaer, L., P. G. Ashton-Rickardt, H. L. Ploegh, and S. Tonegawa. 1992. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD428+ T cells. Cell 71: 1205-1214.
7. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
8. Saric, T., S.C. Chang,A. Hattori, I. A. York, S.Markant, K. L. Rock, M.Tsujimoto, and A. L. Goldberg. 2002. An IFN-g-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176.
9. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1: 533-541.
10. Grandea III, A. G., T. N. Golovina, S. E. Hamilton, V. Sriram, T. Spies, R. R. Brutkiewicz, J. T. Harty, L. C. Eisenlohr, and L. Van Kaer. 2000. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13: 213-222.
11. Hammer, G. E., F. Gonzalez, E. James, H. Nolla, and N. Shastri. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8: 101-108.
12. Blanchard, N., and N. Shastri. 2008. Coping with loss of perfection in the MHC class I peptide repertoire. Curr. Opin. Immunol. 20: 82-88.
13. Kincaid, E. Z., J. W. Che, I. York, H. Escobar, E. Reyes-Vargas, J. C. Delgado, R. M. Welsh, M. L. Karow, A. J. Murphy, D. M. Valenzuela, et al. 2011. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat. Immunol. 13: 129-135.
14. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
15. Yan, J., V. V. Parekh, Y. Mendez-Fernandez, D. Olivares-Villagómez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer. 2006. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J. Exp. Med. 203: 647-659.
16. York, I. A., M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock. 2006. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103: 9202-9207.
17. Firat, E., L. Saveanu, P. Aichele, P. Staeheli, J. Huai, S. Gaedicke, A. Nil, G. Besin, B. Kanzler, P. van Endert, and G. Niedermann. 2007. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178: 2241-2248.
18. Fruci, D., P. Giacomini, M. R. Nicotra, M. Forloni, R. Fraioli, L. Saveanu, P. van Endert, and P. G. Natali. 2008. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J. Cell. Physiol. 216: 742-749.
19. Strange, A., F. Capon, C. C. Spencer, J. Knight, M. E. Weale, M. H. Allen, A. Barton, G. Band, C. Bellenguez, J. G. Bergboer, et al; Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42: 985-990.
20. Evans, D. M., C. C. Spencer, J. J. Pointon, Z. Su, D. Harvey, G. Kochan, U. Oppermann, A. Dilthey,M. Pirinen,M. A. Stone, et al; Spondyloarthritis Research Consortium of Canada (SPARCC); Australo-Anglo-American Spondyloarthritis Consortium (TASC);Wellcome Trust Case Control Consortium 2 (WTCCC2). 2011. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. [Published erratum appears in 2011 Nat. Genet. 43: 919.] Nat. Genet. 43: 761-767.
21. Nagarajan, N. A., F. Gonzalez, and N. Shastri. 2012. Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat. Immunol. 13: 579-586.
22. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6: 883-894.
23. Lantz, O., and A. Bendelac. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4282 T cells in mice and humans. J. Exp. Med. 180: 1097-1106.
24. Tilloy, F., E. Treiner, S. H. Park, C. Garcia, F. Lemonnier, H. de la Salle, A. Bendelac, M. Bonneville, and O. Lantz. 1999. An invariant T cell receptor a chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted a/b T cell subpopulation in mammals. J. Exp. Med. 189: 1907-1921.
25. Reantragoon, R., L. Kjer-Nielsen, O. Patel, Z. Chen, P. T. Illing, M. Bhati, L. Kostenko, M. Bharadwaj, B. Meehan, T. H. Hansen, et al. 2012. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med. 209: 761-774.
26. Swift, S., J. Lorens, P. Achacoso, and G. P. Nolan. 2001. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr. Protoc. Immunol. Chapter 10: Unit 10.17C.
27. Kouskoff, V., K. Signorelli, C. Benoist, and D. Mathis. 1995. Cassette vectors directing expression of T cell receptor genes in transgenic mice. J. Immunol. Methods 180: 273-280.
28. Glaichenhaus, N., C. Davis, K. Bornschlegel, J. P. Allison, and N. Shastri. 1991. A novel strategy for the generation of T cell lines lacking expression of endogenous alpha-and/or beta-chain T cell receptor genes. J. Immunol. 146: 2095-2101.
29. Dash, P., J. L. McClaren, T. H. Oguin, III, W. Rothwell, B. Todd, M. Y. Morris, J. Becksfort, C. Reynolds, S. A. Brown, P. C. Doherty, and P. G. Thomas. 2011. Paired analysis of TCRa and TCRb chains at the single-cell level in mice. J. Clin. Invest. 121: 288-295.
30. Letourneur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor a and b chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur. J. Immunol. 19: 2269-2274.
31. Davis, M. M., and P. J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402.
32. Rossjohn, J., S. Gras, J. J. Miles, S. J. Turner, D. I. Godfrey, and J. McCluskey. 2015. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33: 169-200.
33. Lefranc, M. P., V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, et al. 2009. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37: D1006-D1012.
34. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Kedl, and M. K. Jenkins. 2007. Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
35. Moon, J. J., H. H. Chu, J. Hataye, A. J. Pagán, M. Pepper, J. B. McLachlan, T. Zell, and M. K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4: 565-581.
36. Utsunomiya, Y., J. Bill, E. Palmer, K. Gollob, Y. Takagaki, and O. Kanagawa. 1989. Analysis of a monoclonal rat antibody directed to the alpha-chain variable region (V alpha 3) of the mouse T cell antigen receptor. J. Immunol. 143: 2602-2608.
37. Pircher, H., N. Reba?, M. Groettrup, C. Grégoire, D. E. Speiser, M. P. Happ, E. Palmer, R. M. Zinkernagel, H. Hengartner, and B. Malissen. 1992. Preferential positive selection of Va2+CD8+ T cells in mouse strains expressing both H-2k and T cell receptor Va a haplotypes: determination with a Va2-specific monoclonal antibody. Eur. J. Immunol. 22: 399-404.
38. Salio, M., J. D. Silk, E. Y. Jones, and V. Cerundolo. 2014. Biology of CD1-and MR1-restricted T cells. Annu. Rev. Immunol. 32: 323-366.
39. Brennan, P. J., M. Brigl, and M. B. Brenner. 2013. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13: 101-117.
40. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
41. Huster, K. M., V. Busch, M. Schiemann, K. Linkemann, K. M. Kerksiek, H. Wagner, and D. H. Busch. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. USA 101: 5610-5615.
42. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6: 369-376.
43. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
44. Rossjohn, J., D. G. Pellicci, O. Patel, L. Gapin, and D. I. Godfrey. 2012. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12: 845-857.
45. Godfrey, D. I., A. P. Uldrich, J. McCluskey, J. Rossjohn, and D. B. Moody. 2015. The burgeoning family of unconventional T cells. Nat. Immunol. 16: 1114-1123.
46. Borg, N. A., K. S. Wun, L. Kjer-Nielsen, M. C. Wilce, D. G. Pellicci, R. Koh, G. S. Besra, M. Bharadwaj, D. I. Godfrey, J. McCluskey, and J. Rossjohn. 2007. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448: 44-49.
47. Mallevaey, T., J. P. Scott-Browne, J. L. Matsuda, M. H. Young, D. G. Pellicci, O. Patel, M. Thakur, L. Kjer-Nielsen, S. K. Richardson, V. Cerundolo, et al. 2009. T cell receptor CDR2b and CDR3b loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31: 60-71.
48. Pellicci, D. G., O. Patel, L. Kjer-Nielsen, S. S. Pang, L. C. Sullivan, K. Kyparissoudis, A. G. Brooks, H. H. Reid, S. Gras, I. S. Lucet, et al. 2009. Differential recognition of CD1d-a-galactosyl ceramide by the Vb8.2 and Vb7 semi-invariant NKT T cell receptors. Immunity 31: 47-59.
49. Patel, O., D. G. Pellicci, A. P. Uldrich, L. C. Sullivan, M. Bhati, M. McKnight, S. K. Richardson, A. R. Howell, T. Mallevaey, J. Zhang, et al. 2011. Vb2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proc. Natl. Acad. Sci. USA 108: 19007-19012.
50. Patel, O., L. Kjer-Nielsen, J. Le Nours, S. B. Eckle, R. Birkinshaw, T. Beddoe, A. J. Corbett, L. Liu, J. J. Miles, B. Meehan, et al. 2013. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4: 2142.
51. López-Sagaseta, J., C. L. Dulberger, J. E. Crooks, C. D. Parks, A. M. Luoma, A. McFedries, I. Van Rhijn, A. Saghatelian, and E. J. Adams. 2013. The molecular basis for mucosal-associated invariant T cell recognition of MR1 proteins. Proc. Natl. Acad. Sci. USA 110: E1771-E1778.
52. Engel, I., and M. Kronenberg. 2014. Transcriptional control of the development and function of Va14i NKT cells. Curr. Top. Microbiol. Immunol. 381: 51-81.
53. Engel, I., and M. Kronenberg. 2012. Making memory at birth: understanding the differentiation of natural killer T cells. Curr. Opin. Immunol. 24: 184-190.
54. Bezbradica, J. S., T. Hill, A. K. Stanic, L. Van Kaer, and S. Joyce. 2005. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102: 5114-5119.
55. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Va14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716.
56. D'Cruz, L. M., J. Knell, J. K. Fujimoto, and A. W. Goldrath. 2010. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat. Immunol. 11: 240-249.
57. Urdahl, K. B., J. C. Sun, and M. J. Bevan. 2002. Positive selection of MHC class Ib-restricted CD8+ T cells on hematopoietic cells. Nat. Immunol. 3: 772-779.
58. Rodgers, J. R., and R. G. Cook. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5: 459-471.